A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections.

Trial Profile

A Prospective, Randomized, Double-Blind, Multicenter Study to Establish the Safety and Tolerability of Doripenem Compared With Meropenem in Hospitalized Children With Complicated Intra-Abdominal Infections.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 04 Sep 2014

At a glance

  • Drugs Doripenem (Primary) ; Amoxicillin/clavulanic acid; Meropenem
  • Indications Bacterial infections; Intra-abdominal infections
  • Focus Adverse reactions; Registrational
  • Sponsors Janssen Research & Development
  • Most Recent Events

    • 01 Sep 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 03 Nov 2011 Planned End Date changed from 1 Apr 2013 to 1 Apr 2014 as reported by ClinicalTrials.gov.
    • 09 Jun 2011 Additional location [Chile, India] identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top